Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery

Clinical trial NCT03384836 · SUSPENDED

Trial details

NCT number: NCT03384836
Sponsor: Roswell Park Cancer Institute
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7

Start date: 2018-01-31
Primary completion: 2027-05-31
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.